Bleuacacia Ltd
Bleuacacia Ltd Fundamental Analysis
Bleuacacia Ltd (BLEUW) shows weak financial fundamentals with a PE ratio of 53.11, profit margin of 0.00%, and ROE of 2.81%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 26.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze BLEUW's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBLEUW demonstrates superior asset utilization.
Valuation Score
ModerateBLEUW shows balanced valuation metrics.
Growth Score
WeakBLEUW faces weak or negative growth trends.
Financial Health Score
ModerateBLEUW shows balanced financial health with some risks.
Profitability Score
WeakBLEUW struggles to sustain strong margins.
Key Financial Metrics
Is BLEUW Expensive or Cheap?
P/E Ratio
BLEUW trades at 53.11 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, BLEUW's PEG of 0.53 indicates potential undervaluation.
Price to Book
The market values Bleuacacia Ltd at 36.65 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 20.45 times EBITDA. This signals the market has high growth expectations.
How Well Does BLEUW Make Money?
Net Profit Margin
For every $100 in sales, Bleuacacia Ltd keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.81 in profit for every $100 of shareholder equity.
ROA
Bleuacacia Ltd generates $22.66 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.03 in free cash annually.
FCF Yield
BLEUW converts -0.75% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
53.11
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.53
vs 25 benchmark
P/B Ratio
Price to book value ratio
36.65
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.16
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.04
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.03
vs 25 benchmark
ROA
Return on assets percentage
0.23
vs 25 benchmark
ROCE
Return on capital employed
-0.10
vs 25 benchmark
How BLEUW Stacks Against Its Sector Peers
| Metric | BLEUW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 53.11 | 19.32 | Worse (Expensive) |
| ROE | 2.81% | 805.00% | Weak |
| Net Margin | 0.00% | 3869.00% | Weak |
| Debt/Equity | 0.16 | 0.85 | Strong (Low Leverage) |
| Current Ratio | 0.04 | 624.16 | Weak Liquidity |
| ROA | 22.66% | -23510.00% (disorted) | Strong |
BLEUW outperforms its industry in 2 out of 6 key metrics, particularly excelling in ROA, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Bleuacacia Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical